Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Vector Oncology
ClinicalTrials.gov Identifier:
NCT01330966
First received: April 6, 2011
Last updated: September 21, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)